Global mRNA Vaccine and Therapeutics Raw Material Production, Demand and Key Producers, 2022-2028
This report studies the global mRNA Vaccine and Therapeutics Raw Material production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for mRNA Vaccine and Therapeutics Raw Material, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of mRNA Vaccine and Therapeutics Raw Material that contribute to its increasing demand across many markets.
The global mRNA Vaccine and Therapeutics Raw Material market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global mRNA Vaccine and Therapeutics Raw Material total production and demand, 2017-2028, (K Units)
Global mRNA Vaccine and Therapeutics Raw Material total production value, 2017-2028, (USD Million)
Global mRNA Vaccine and Therapeutics Raw Material production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global mRNA Vaccine and Therapeutics Raw Material consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: mRNA Vaccine and Therapeutics Raw Material domestic production, consumption, key domestic manufacturers and share
Global mRNA Vaccine and Therapeutics Raw Material production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global mRNA Vaccine and Therapeutics Raw Material production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global mRNA Vaccine and Therapeutics Raw Material production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global mRNA Vaccine and Therapeutics Raw Material market based on the following parameters – headquarters, production locations, products portfolio, mRNA Vaccine and Therapeutics Raw Material revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World mRNA Vaccine and Therapeutics Raw Material market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global mRNA Vaccine and Therapeutics Raw Material Market, By Region:
1. How big is the global mRNA Vaccine and Therapeutics Raw Material market?
2. What is the demand of the global mRNA Vaccine and Therapeutics Raw Material market?
3. What is the year over year growth of the global mRNA Vaccine and Therapeutics Raw Material market?
4. What is the production and production value of the global mRNA Vaccine and Therapeutics Raw Material market?
5. Who are the key producers in the global mRNA Vaccine and Therapeutics Raw Material market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for mRNA Vaccine and Therapeutics Raw Material, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of mRNA Vaccine and Therapeutics Raw Material that contribute to its increasing demand across many markets.
The global mRNA Vaccine and Therapeutics Raw Material market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global mRNA Vaccine and Therapeutics Raw Material total production and demand, 2017-2028, (K Units)
Global mRNA Vaccine and Therapeutics Raw Material total production value, 2017-2028, (USD Million)
Global mRNA Vaccine and Therapeutics Raw Material production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global mRNA Vaccine and Therapeutics Raw Material consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: mRNA Vaccine and Therapeutics Raw Material domestic production, consumption, key domestic manufacturers and share
Global mRNA Vaccine and Therapeutics Raw Material production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global mRNA Vaccine and Therapeutics Raw Material production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global mRNA Vaccine and Therapeutics Raw Material production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global mRNA Vaccine and Therapeutics Raw Material market based on the following parameters – headquarters, production locations, products portfolio, mRNA Vaccine and Therapeutics Raw Material revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World mRNA Vaccine and Therapeutics Raw Material market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global mRNA Vaccine and Therapeutics Raw Material Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Infectious Disease Vaccines
- Cancer Vaccine
- Others
- Hospitals and Clinics
- Outpatient and Surgery Centers
- Others
- Jena Bioscience
- Thermo Fisher Scientific Inc.
- SBS Genetech
- Lucigen
- Sigma Aldrich
- Moderna Therapeutics
- CureVac
- Translate Bio
- BioNTech
- Sangamo Therapeutics
- Argos Therapeutics
- In-Cell-Art
- Etherna
- Ethris
- Tiba Biotechnology
- Product Type Insights
1. How big is the global mRNA Vaccine and Therapeutics Raw Material market?
2. What is the demand of the global mRNA Vaccine and Therapeutics Raw Material market?
3. What is the year over year growth of the global mRNA Vaccine and Therapeutics Raw Material market?
4. What is the production and production value of the global mRNA Vaccine and Therapeutics Raw Material market?
5. Who are the key producers in the global mRNA Vaccine and Therapeutics Raw Material market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 mRNA Vaccine and Therapeutics Raw Material Introduction
1.2 World mRNA Vaccine and Therapeutics Raw Material Supply & Forecast
1.2.1 World mRNA Vaccine and Therapeutics Raw Material Production Value (2017 & 2021 & 2028)
1.2.2 World mRNA Vaccine and Therapeutics Raw Material Production (2017-2028)
1.2.3 World mRNA Vaccine and Therapeutics Raw Material Pricing Trends (2017-2028)
1.3 World mRNA Vaccine and Therapeutics Raw Material Production by Region
1.3.1 World mRNA Vaccine and Therapeutics Raw Material Production Value by Region (2017-2028)
1.3.2 World mRNA Vaccine and Therapeutics Raw Material Production by Region (2017-2028)
1.3.3 World mRNA Vaccine and Therapeutics Raw Material Average Price by Region (2017-2028)
1.3.4 North America mRNA Vaccine and Therapeutics Raw Material Production (2017-2028)
1.3.5 Europe mRNA Vaccine and Therapeutics Raw Material Production (2017-2028)
1.3.6 China mRNA Vaccine and Therapeutics Raw Material Production (2017-2028)
1.3.7 Japan mRNA Vaccine and Therapeutics Raw Material Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 mRNA Vaccine and Therapeutics Raw Material Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 mRNA Vaccine and Therapeutics Raw Material Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World mRNA Vaccine and Therapeutics Raw Material Demand (2017-2028)
2.2 World mRNA Vaccine and Therapeutics Raw Material Consumption by Region
2.2.1 World mRNA Vaccine and Therapeutics Raw Material Consumption by Region (2017-2022)
2.2.2 World mRNA Vaccine and Therapeutics Raw Material Consumption Forecast by Region (2023-2028)
2.3 United States mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028)
2.4 China mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028)
2.5 Europe mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028)
2.6 Japan mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028)
2.7 South Korea mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028)
2.8 ASEAN mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028)
2.9 India mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028)
3 WORLD MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World mRNA Vaccine and Therapeutics Raw Material Production Value by Manufacturer (2017-2022)
3.2 World mRNA Vaccine and Therapeutics Raw Material Production by Manufacturer (2017-2022)
3.3 World mRNA Vaccine and Therapeutics Raw Material Average Price by Manufacturer (2017-2022)
3.4 mRNA Vaccine and Therapeutics Raw Material Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global mRNA Vaccine and Therapeutics Raw Material Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for mRNA Vaccine and Therapeutics Raw Material in 2021
3.5.3 Global Concentration Ratios (CR8) for mRNA Vaccine and Therapeutics Raw Material in 2021
3.6 mRNA Vaccine and Therapeutics Raw Material Market: Overall Company Footprint Analysis
3.6.1 mRNA Vaccine and Therapeutics Raw Material Market: Region Footprint
3.6.2 mRNA Vaccine and Therapeutics Raw Material Market: Company Product Type Footprint
3.6.3 mRNA Vaccine and Therapeutics Raw Material Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: mRNA Vaccine and Therapeutics Raw Material Production Value Comparison
4.1.1 United States VS China: mRNA Vaccine and Therapeutics Raw Material Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: mRNA Vaccine and Therapeutics Raw Material Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: mRNA Vaccine and Therapeutics Raw Material Production Comparison
4.2.1 United States VS China: mRNA Vaccine and Therapeutics Raw Material Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: mRNA Vaccine and Therapeutics Raw Material Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: mRNA Vaccine and Therapeutics Raw Material Consumption Comparison
4.3.1 United States VS China: mRNA Vaccine and Therapeutics Raw Material Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: mRNA Vaccine and Therapeutics Raw Material Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States mRNA Vaccine and Therapeutics Raw Material Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of mRNA Vaccine and Therapeutics Raw Material in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States mRNA Vaccine and Therapeutics Raw Material Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States mRNA Vaccine and Therapeutics Raw Material Production by Domestic Manufacturer, (2017-2022)
4.5 China mRNA Vaccine and Therapeutics Raw Material Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of mRNA Vaccine and Therapeutics Raw Material in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China mRNA Vaccine and Therapeutics Raw Material Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China mRNA Vaccine and Therapeutics Raw Material Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World mRNA Vaccine and Therapeutics Raw Material Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of mRNA Vaccine and Therapeutics Raw Material in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World mRNA Vaccine and Therapeutics Raw Material Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World mRNA Vaccine and Therapeutics Raw Material Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World mRNA Vaccine and Therapeutics Raw Material Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Infectious Disease Vaccines
5.2.2 Cancer Vaccine
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World mRNA Vaccine and Therapeutics Raw Material Production by Type (2017-2028)
5.3.2 World mRNA Vaccine and Therapeutics Raw Material Production Value by Type (2017-2028)
5.3.3 World mRNA Vaccine and Therapeutics Raw Material Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World mRNA Vaccine and Therapeutics Raw Material Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospitals and Clinics
6.2.2 Outpatient and Surgery Centers
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World mRNA Vaccine and Therapeutics Raw Material Production by Application (2017-2028)
6.3.2 World mRNA Vaccine and Therapeutics Raw Material Production Value by Application (2017-2028)
6.3.3 World mRNA Vaccine and Therapeutics Raw Material Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Jena Bioscience
7.1.1 Jena Bioscience Details
7.1.2 Jena Bioscience Major Business
7.1.3 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product and Services
7.1.4 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Jena Bioscience Recent Developments/Updates
7.1.6 Jena Bioscience Competitive Strengths & Weaknesses
7.2 Thermo Fisher Scientific Inc.
7.2.1 Thermo Fisher Scientific Inc. Details
7.2.2 Thermo Fisher Scientific Inc. Major Business
7.2.3 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product and Services
7.2.4 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
7.2.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
7.3 SBS Genetech
7.3.1 SBS Genetech Details
7.3.2 SBS Genetech Major Business
7.3.3 SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product and Services
7.3.4 SBS Genetech mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 SBS Genetech Recent Developments/Updates
7.3.6 SBS Genetech Competitive Strengths & Weaknesses
7.4 Lucigen
7.4.1 Lucigen Details
7.4.2 Lucigen Major Business
7.4.3 Lucigen mRNA Vaccine and Therapeutics Raw Material Product and Services
7.4.4 Lucigen mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Lucigen Recent Developments/Updates
7.4.6 Lucigen Competitive Strengths & Weaknesses
7.5 Sigma Aldrich
7.5.1 Sigma Aldrich Details
7.5.2 Sigma Aldrich Major Business
7.5.3 Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product and Services
7.5.4 Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Sigma Aldrich Recent Developments/Updates
7.5.6 Sigma Aldrich Competitive Strengths & Weaknesses
7.6 Moderna Therapeutics
7.6.1 Moderna Therapeutics Details
7.6.2 Moderna Therapeutics Major Business
7.6.3 Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product and Services
7.6.4 Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Moderna Therapeutics Recent Developments/Updates
7.6.6 Moderna Therapeutics Competitive Strengths & Weaknesses
7.7 CureVac
7.7.1 CureVac Details
7.7.2 CureVac Major Business
7.7.3 CureVac mRNA Vaccine and Therapeutics Raw Material Product and Services
7.7.4 CureVac mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 CureVac Recent Developments/Updates
7.7.6 CureVac Competitive Strengths & Weaknesses
7.8 Translate Bio
7.8.1 Translate Bio Details
7.8.2 Translate Bio Major Business
7.8.3 Translate Bio mRNA Vaccine and Therapeutics Raw Material Product and Services
7.8.4 Translate Bio mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Translate Bio Recent Developments/Updates
7.8.6 Translate Bio Competitive Strengths & Weaknesses
7.9 BioNTech
7.9.1 BioNTech Details
7.9.2 BioNTech Major Business
7.9.3 BioNTech mRNA Vaccine and Therapeutics Raw Material Product and Services
7.9.4 BioNTech mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 BioNTech Recent Developments/Updates
7.9.6 BioNTech Competitive Strengths & Weaknesses
7.10 Sangamo Therapeutics
7.10.1 Sangamo Therapeutics Details
7.10.2 Sangamo Therapeutics Major Business
7.10.3 Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product and Services
7.10.4 Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Sangamo Therapeutics Recent Developments/Updates
7.10.6 Sangamo Therapeutics Competitive Strengths & Weaknesses
7.11 Argos Therapeutics
7.11.1 Argos Therapeutics Details
7.11.2 Argos Therapeutics Major Business
7.11.3 Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product and Services
7.11.4 Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Argos Therapeutics Recent Developments/Updates
7.11.6 Argos Therapeutics Competitive Strengths & Weaknesses
7.12 In-Cell-Art
7.12.1 In-Cell-Art Details
7.12.2 In-Cell-Art Major Business
7.12.3 In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product and Services
7.12.4 In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 In-Cell-Art Recent Developments/Updates
7.12.6 In-Cell-Art Competitive Strengths & Weaknesses
7.13 Etherna
7.13.1 Etherna Details
7.13.2 Etherna Major Business
7.13.3 Etherna mRNA Vaccine and Therapeutics Raw Material Product and Services
7.13.4 Etherna mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Etherna Recent Developments/Updates
7.13.6 Etherna Competitive Strengths & Weaknesses
7.14 Ethris
7.14.1 Ethris Details
7.14.2 Ethris Major Business
7.14.3 Ethris mRNA Vaccine and Therapeutics Raw Material Product and Services
7.14.4 Ethris mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Ethris Recent Developments/Updates
7.14.6 Ethris Competitive Strengths & Weaknesses
7.15 Tiba Biotechnology
7.15.1 Tiba Biotechnology Details
7.15.2 Tiba Biotechnology Major Business
7.15.3 Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product and Services
7.15.4 Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Tiba Biotechnology Recent Developments/Updates
7.15.6 Tiba Biotechnology Competitive Strengths & Weaknesses
7.16 Product Type Insights
7.16.1 Product Type Insights Details
7.16.2 Product Type Insights Major Business
7.16.3 Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product and Services
7.16.4 Product Type Insights mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Product Type Insights Recent Developments/Updates
7.16.6 Product Type Insights Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of mRNA Vaccine and Therapeutics Raw Material and Key Manufacturers
8.2 mRNA Vaccine and Therapeutics Raw Material Manufacturing Costs
8.3 mRNA Vaccine and Therapeutics Raw Material Production Process
8.4 mRNA Vaccine and Therapeutics Raw Material Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for mRNA Vaccine and Therapeutics Raw Material Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 mRNA Vaccine and Therapeutics Raw Material Typical Distributors
9.3 mRNA Vaccine and Therapeutics Raw Material Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 mRNA Vaccine and Therapeutics Raw Material Introduction
1.2 World mRNA Vaccine and Therapeutics Raw Material Supply & Forecast
1.2.1 World mRNA Vaccine and Therapeutics Raw Material Production Value (2017 & 2021 & 2028)
1.2.2 World mRNA Vaccine and Therapeutics Raw Material Production (2017-2028)
1.2.3 World mRNA Vaccine and Therapeutics Raw Material Pricing Trends (2017-2028)
1.3 World mRNA Vaccine and Therapeutics Raw Material Production by Region
1.3.1 World mRNA Vaccine and Therapeutics Raw Material Production Value by Region (2017-2028)
1.3.2 World mRNA Vaccine and Therapeutics Raw Material Production by Region (2017-2028)
1.3.3 World mRNA Vaccine and Therapeutics Raw Material Average Price by Region (2017-2028)
1.3.4 North America mRNA Vaccine and Therapeutics Raw Material Production (2017-2028)
1.3.5 Europe mRNA Vaccine and Therapeutics Raw Material Production (2017-2028)
1.3.6 China mRNA Vaccine and Therapeutics Raw Material Production (2017-2028)
1.3.7 Japan mRNA Vaccine and Therapeutics Raw Material Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 mRNA Vaccine and Therapeutics Raw Material Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 mRNA Vaccine and Therapeutics Raw Material Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World mRNA Vaccine and Therapeutics Raw Material Demand (2017-2028)
2.2 World mRNA Vaccine and Therapeutics Raw Material Consumption by Region
2.2.1 World mRNA Vaccine and Therapeutics Raw Material Consumption by Region (2017-2022)
2.2.2 World mRNA Vaccine and Therapeutics Raw Material Consumption Forecast by Region (2023-2028)
2.3 United States mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028)
2.4 China mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028)
2.5 Europe mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028)
2.6 Japan mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028)
2.7 South Korea mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028)
2.8 ASEAN mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028)
2.9 India mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028)
3 WORLD MRNA VACCINE AND THERAPEUTICS RAW MATERIAL MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World mRNA Vaccine and Therapeutics Raw Material Production Value by Manufacturer (2017-2022)
3.2 World mRNA Vaccine and Therapeutics Raw Material Production by Manufacturer (2017-2022)
3.3 World mRNA Vaccine and Therapeutics Raw Material Average Price by Manufacturer (2017-2022)
3.4 mRNA Vaccine and Therapeutics Raw Material Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global mRNA Vaccine and Therapeutics Raw Material Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for mRNA Vaccine and Therapeutics Raw Material in 2021
3.5.3 Global Concentration Ratios (CR8) for mRNA Vaccine and Therapeutics Raw Material in 2021
3.6 mRNA Vaccine and Therapeutics Raw Material Market: Overall Company Footprint Analysis
3.6.1 mRNA Vaccine and Therapeutics Raw Material Market: Region Footprint
3.6.2 mRNA Vaccine and Therapeutics Raw Material Market: Company Product Type Footprint
3.6.3 mRNA Vaccine and Therapeutics Raw Material Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: mRNA Vaccine and Therapeutics Raw Material Production Value Comparison
4.1.1 United States VS China: mRNA Vaccine and Therapeutics Raw Material Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: mRNA Vaccine and Therapeutics Raw Material Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: mRNA Vaccine and Therapeutics Raw Material Production Comparison
4.2.1 United States VS China: mRNA Vaccine and Therapeutics Raw Material Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: mRNA Vaccine and Therapeutics Raw Material Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: mRNA Vaccine and Therapeutics Raw Material Consumption Comparison
4.3.1 United States VS China: mRNA Vaccine and Therapeutics Raw Material Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: mRNA Vaccine and Therapeutics Raw Material Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States mRNA Vaccine and Therapeutics Raw Material Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of mRNA Vaccine and Therapeutics Raw Material in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States mRNA Vaccine and Therapeutics Raw Material Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States mRNA Vaccine and Therapeutics Raw Material Production by Domestic Manufacturer, (2017-2022)
4.5 China mRNA Vaccine and Therapeutics Raw Material Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of mRNA Vaccine and Therapeutics Raw Material in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China mRNA Vaccine and Therapeutics Raw Material Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China mRNA Vaccine and Therapeutics Raw Material Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World mRNA Vaccine and Therapeutics Raw Material Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of mRNA Vaccine and Therapeutics Raw Material in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World mRNA Vaccine and Therapeutics Raw Material Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World mRNA Vaccine and Therapeutics Raw Material Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World mRNA Vaccine and Therapeutics Raw Material Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Infectious Disease Vaccines
5.2.2 Cancer Vaccine
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World mRNA Vaccine and Therapeutics Raw Material Production by Type (2017-2028)
5.3.2 World mRNA Vaccine and Therapeutics Raw Material Production Value by Type (2017-2028)
5.3.3 World mRNA Vaccine and Therapeutics Raw Material Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World mRNA Vaccine and Therapeutics Raw Material Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospitals and Clinics
6.2.2 Outpatient and Surgery Centers
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World mRNA Vaccine and Therapeutics Raw Material Production by Application (2017-2028)
6.3.2 World mRNA Vaccine and Therapeutics Raw Material Production Value by Application (2017-2028)
6.3.3 World mRNA Vaccine and Therapeutics Raw Material Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Jena Bioscience
7.1.1 Jena Bioscience Details
7.1.2 Jena Bioscience Major Business
7.1.3 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product and Services
7.1.4 Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Jena Bioscience Recent Developments/Updates
7.1.6 Jena Bioscience Competitive Strengths & Weaknesses
7.2 Thermo Fisher Scientific Inc.
7.2.1 Thermo Fisher Scientific Inc. Details
7.2.2 Thermo Fisher Scientific Inc. Major Business
7.2.3 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product and Services
7.2.4 Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
7.2.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
7.3 SBS Genetech
7.3.1 SBS Genetech Details
7.3.2 SBS Genetech Major Business
7.3.3 SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product and Services
7.3.4 SBS Genetech mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 SBS Genetech Recent Developments/Updates
7.3.6 SBS Genetech Competitive Strengths & Weaknesses
7.4 Lucigen
7.4.1 Lucigen Details
7.4.2 Lucigen Major Business
7.4.3 Lucigen mRNA Vaccine and Therapeutics Raw Material Product and Services
7.4.4 Lucigen mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Lucigen Recent Developments/Updates
7.4.6 Lucigen Competitive Strengths & Weaknesses
7.5 Sigma Aldrich
7.5.1 Sigma Aldrich Details
7.5.2 Sigma Aldrich Major Business
7.5.3 Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product and Services
7.5.4 Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Sigma Aldrich Recent Developments/Updates
7.5.6 Sigma Aldrich Competitive Strengths & Weaknesses
7.6 Moderna Therapeutics
7.6.1 Moderna Therapeutics Details
7.6.2 Moderna Therapeutics Major Business
7.6.3 Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product and Services
7.6.4 Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Moderna Therapeutics Recent Developments/Updates
7.6.6 Moderna Therapeutics Competitive Strengths & Weaknesses
7.7 CureVac
7.7.1 CureVac Details
7.7.2 CureVac Major Business
7.7.3 CureVac mRNA Vaccine and Therapeutics Raw Material Product and Services
7.7.4 CureVac mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 CureVac Recent Developments/Updates
7.7.6 CureVac Competitive Strengths & Weaknesses
7.8 Translate Bio
7.8.1 Translate Bio Details
7.8.2 Translate Bio Major Business
7.8.3 Translate Bio mRNA Vaccine and Therapeutics Raw Material Product and Services
7.8.4 Translate Bio mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Translate Bio Recent Developments/Updates
7.8.6 Translate Bio Competitive Strengths & Weaknesses
7.9 BioNTech
7.9.1 BioNTech Details
7.9.2 BioNTech Major Business
7.9.3 BioNTech mRNA Vaccine and Therapeutics Raw Material Product and Services
7.9.4 BioNTech mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 BioNTech Recent Developments/Updates
7.9.6 BioNTech Competitive Strengths & Weaknesses
7.10 Sangamo Therapeutics
7.10.1 Sangamo Therapeutics Details
7.10.2 Sangamo Therapeutics Major Business
7.10.3 Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product and Services
7.10.4 Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Sangamo Therapeutics Recent Developments/Updates
7.10.6 Sangamo Therapeutics Competitive Strengths & Weaknesses
7.11 Argos Therapeutics
7.11.1 Argos Therapeutics Details
7.11.2 Argos Therapeutics Major Business
7.11.3 Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product and Services
7.11.4 Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Argos Therapeutics Recent Developments/Updates
7.11.6 Argos Therapeutics Competitive Strengths & Weaknesses
7.12 In-Cell-Art
7.12.1 In-Cell-Art Details
7.12.2 In-Cell-Art Major Business
7.12.3 In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product and Services
7.12.4 In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 In-Cell-Art Recent Developments/Updates
7.12.6 In-Cell-Art Competitive Strengths & Weaknesses
7.13 Etherna
7.13.1 Etherna Details
7.13.2 Etherna Major Business
7.13.3 Etherna mRNA Vaccine and Therapeutics Raw Material Product and Services
7.13.4 Etherna mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Etherna Recent Developments/Updates
7.13.6 Etherna Competitive Strengths & Weaknesses
7.14 Ethris
7.14.1 Ethris Details
7.14.2 Ethris Major Business
7.14.3 Ethris mRNA Vaccine and Therapeutics Raw Material Product and Services
7.14.4 Ethris mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Ethris Recent Developments/Updates
7.14.6 Ethris Competitive Strengths & Weaknesses
7.15 Tiba Biotechnology
7.15.1 Tiba Biotechnology Details
7.15.2 Tiba Biotechnology Major Business
7.15.3 Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product and Services
7.15.4 Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Tiba Biotechnology Recent Developments/Updates
7.15.6 Tiba Biotechnology Competitive Strengths & Weaknesses
7.16 Product Type Insights
7.16.1 Product Type Insights Details
7.16.2 Product Type Insights Major Business
7.16.3 Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product and Services
7.16.4 Product Type Insights mRNA Vaccine and Therapeutics Raw Material Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Product Type Insights Recent Developments/Updates
7.16.6 Product Type Insights Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of mRNA Vaccine and Therapeutics Raw Material and Key Manufacturers
8.2 mRNA Vaccine and Therapeutics Raw Material Manufacturing Costs
8.3 mRNA Vaccine and Therapeutics Raw Material Production Process
8.4 mRNA Vaccine and Therapeutics Raw Material Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for mRNA Vaccine and Therapeutics Raw Material Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 mRNA Vaccine and Therapeutics Raw Material Typical Distributors
9.3 mRNA Vaccine and Therapeutics Raw Material Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World mRNA Vaccine and Therapeutics Raw Material Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World mRNA Vaccine and Therapeutics Raw Material Production Value by Region (2017-2022) & (USD Million)
Table 3. World mRNA Vaccine and Therapeutics Raw Material Production Value by Region (2023-2028) & (USD Million)
Table 4. World mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Region (2017-2022)
Table 5. World mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Region (2023-2028)
Table 6. World mRNA Vaccine and Therapeutics Raw Material Production by Region (2017-2022) & (K Units)
Table 7. World mRNA Vaccine and Therapeutics Raw Material Production by Region (2023-2028) & (K Units)
Table 8. World mRNA Vaccine and Therapeutics Raw Material Production Market Share by Region (2017-2022)
Table 9. World mRNA Vaccine and Therapeutics Raw Material Production Market Share by Region (2023-2028)
Table 10. World mRNA Vaccine and Therapeutics Raw Material Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World mRNA Vaccine and Therapeutics Raw Material Average Price by Region (2023-2028) & (US$/Unit)
Table 12. mRNA Vaccine and Therapeutics Raw Material Major Market Trends
Table 13. World mRNA Vaccine and Therapeutics Raw Material Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World mRNA Vaccine and Therapeutics Raw Material Consumption by Region (2017-2022) & (K Units)
Table 15. World mRNA Vaccine and Therapeutics Raw Material Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World mRNA Vaccine and Therapeutics Raw Material Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key mRNA Vaccine and Therapeutics Raw Material Producers in 2021
Table 18. World mRNA Vaccine and Therapeutics Raw Material Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key mRNA Vaccine and Therapeutics Raw Material Producers in 2021
Table 20. World mRNA Vaccine and Therapeutics Raw Material Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global mRNA Vaccine and Therapeutics Raw Material Company Evaluation Quadrant
Table 22. World mRNA Vaccine and Therapeutics Raw Material Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and mRNA Vaccine and Therapeutics Raw Material Production Site of Key Manufacturer
Table 24. mRNA Vaccine and Therapeutics Raw Material Market: Company Product Type Footprint
Table 25. mRNA Vaccine and Therapeutics Raw Material Market: Company Product Application Footprint
Table 26. mRNA Vaccine and Therapeutics Raw Material Competitive Factors
Table 27. mRNA Vaccine and Therapeutics Raw Material New Entrant and Capacity Expansion Plans
Table 28. mRNA Vaccine and Therapeutics Raw Material Mergers & Acquisitions Activity
Table 29. United States VS China mRNA Vaccine and Therapeutics Raw Material Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China mRNA Vaccine and Therapeutics Raw Material Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China mRNA Vaccine and Therapeutics Raw Material Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of mRNA Vaccine and Therapeutics Raw Material in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States mRNA Vaccine and Therapeutics Raw Material Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States mRNA Vaccine and Therapeutics Raw Material Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States mRNA Vaccine and Therapeutics Raw Material Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of mRNA Vaccine and Therapeutics Raw Material in China, Company Headquarters and Production Place (Province, Country)
Table 38. China mRNA Vaccine and Therapeutics Raw Material Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China mRNA Vaccine and Therapeutics Raw Material Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China mRNA Vaccine and Therapeutics Raw Material Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of mRNA Vaccine and Therapeutics Raw Material in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World mRNA Vaccine and Therapeutics Raw Material Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World mRNA Vaccine and Therapeutics Raw Material Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World mRNA Vaccine and Therapeutics Raw Material Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World mRNA Vaccine and Therapeutics Raw Material Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World mRNA Vaccine and Therapeutics Raw Material Production by Type (2017-2022) & (K Units)
Table 49. World mRNA Vaccine and Therapeutics Raw Material Production by Type (2023-2028) & (K Units)
Table 50. World mRNA Vaccine and Therapeutics Raw Material Production Value by Type (2017-2022) & (USD Million)
Table 51. World mRNA Vaccine and Therapeutics Raw Material Production Value by Type (2023-2028) & (USD Million)
Table 52. World mRNA Vaccine and Therapeutics Raw Material Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World mRNA Vaccine and Therapeutics Raw Material Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World mRNA Vaccine and Therapeutics Raw Material Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World mRNA Vaccine and Therapeutics Raw Material Production by Application (2017-2022) & (K Units)
Table 56. World mRNA Vaccine and Therapeutics Raw Material Production by Application (2023-2028) & (K Units)
Table 57. World mRNA Vaccine and Therapeutics Raw Material Production Value by Application (2017-2022) & (USD Million)
Table 58. World mRNA Vaccine and Therapeutics Raw Material Production Value by Application (2023-2028) & (USD Million)
Table 59. World mRNA Vaccine and Therapeutics Raw Material Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World mRNA Vaccine and Therapeutics Raw Material Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Jena Bioscience Basic Information, Manufacturing Base and Competitors
Table 62. Jena Bioscience Major Business
Table 63. Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 64. Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Jena Bioscience Recent Developments/Updates
Table 66. Jena Bioscience Competitive Strengths & Weaknesses
Table 67. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Thermo Fisher Scientific Inc. Major Business
Table 69. Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 70. Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 72. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 73. SBS Genetech Basic Information, Manufacturing Base and Competitors
Table 74. SBS Genetech Major Business
Table 75. SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 76. SBS Genetech mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. SBS Genetech Recent Developments/Updates
Table 78. SBS Genetech Competitive Strengths & Weaknesses
Table 79. Lucigen Basic Information, Manufacturing Base and Competitors
Table 80. Lucigen Major Business
Table 81. Lucigen mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 82. Lucigen mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Lucigen Recent Developments/Updates
Table 84. Lucigen Competitive Strengths & Weaknesses
Table 85. Sigma Aldrich Basic Information, Manufacturing Base and Competitors
Table 86. Sigma Aldrich Major Business
Table 87. Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 88. Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Sigma Aldrich Recent Developments/Updates
Table 90. Sigma Aldrich Competitive Strengths & Weaknesses
Table 91. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 92. Moderna Therapeutics Major Business
Table 93. Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 94. Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Moderna Therapeutics Recent Developments/Updates
Table 96. Moderna Therapeutics Competitive Strengths & Weaknesses
Table 97. CureVac Basic Information, Manufacturing Base and Competitors
Table 98. CureVac Major Business
Table 99. CureVac mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 100. CureVac mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. CureVac Recent Developments/Updates
Table 102. CureVac Competitive Strengths & Weaknesses
Table 103. Translate Bio Basic Information, Manufacturing Base and Competitors
Table 104. Translate Bio Major Business
Table 105. Translate Bio mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 106. Translate Bio mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Translate Bio Recent Developments/Updates
Table 108. Translate Bio Competitive Strengths & Weaknesses
Table 109. BioNTech Basic Information, Manufacturing Base and Competitors
Table 110. BioNTech Major Business
Table 111. BioNTech mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 112. BioNTech mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. BioNTech Recent Developments/Updates
Table 114. BioNTech Competitive Strengths & Weaknesses
Table 115. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 116. Sangamo Therapeutics Major Business
Table 117. Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 118. Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Sangamo Therapeutics Recent Developments/Updates
Table 120. Sangamo Therapeutics Competitive Strengths & Weaknesses
Table 121. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 122. Argos Therapeutics Major Business
Table 123. Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 124. Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Argos Therapeutics Recent Developments/Updates
Table 126. Argos Therapeutics Competitive Strengths & Weaknesses
Table 127. In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table 128. In-Cell-Art Major Business
Table 129. In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 130. In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. In-Cell-Art Recent Developments/Updates
Table 132. In-Cell-Art Competitive Strengths & Weaknesses
Table 133. Etherna Basic Information, Manufacturing Base and Competitors
Table 134. Etherna Major Business
Table 135. Etherna mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 136. Etherna mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Etherna Recent Developments/Updates
Table 138. Etherna Competitive Strengths & Weaknesses
Table 139. Ethris Basic Information, Manufacturing Base and Competitors
Table 140. Ethris Major Business
Table 141. Ethris mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 142. Ethris mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Ethris Recent Developments/Updates
Table 144. Ethris Competitive Strengths & Weaknesses
Table 145. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table 146. Tiba Biotechnology Major Business
Table 147. Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 148. Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Tiba Biotechnology Recent Developments/Updates
Table 150. Product Type Insights Basic Information, Manufacturing Base and Competitors
Table 151. Product Type Insights Major Business
Table 152. Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 153. Product Type Insights mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 154. mRNA Vaccine and Therapeutics Raw Material Raw Material
Table 155. Key Manufacturers of mRNA Vaccine and Therapeutics Raw Material Raw Materials
Table 156. mRNA Vaccine and Therapeutics Raw Material Typical Distributors
Table 157. mRNA Vaccine and Therapeutics Raw Material Typical Customers
Table 1. World mRNA Vaccine and Therapeutics Raw Material Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World mRNA Vaccine and Therapeutics Raw Material Production Value by Region (2017-2022) & (USD Million)
Table 3. World mRNA Vaccine and Therapeutics Raw Material Production Value by Region (2023-2028) & (USD Million)
Table 4. World mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Region (2017-2022)
Table 5. World mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Region (2023-2028)
Table 6. World mRNA Vaccine and Therapeutics Raw Material Production by Region (2017-2022) & (K Units)
Table 7. World mRNA Vaccine and Therapeutics Raw Material Production by Region (2023-2028) & (K Units)
Table 8. World mRNA Vaccine and Therapeutics Raw Material Production Market Share by Region (2017-2022)
Table 9. World mRNA Vaccine and Therapeutics Raw Material Production Market Share by Region (2023-2028)
Table 10. World mRNA Vaccine and Therapeutics Raw Material Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World mRNA Vaccine and Therapeutics Raw Material Average Price by Region (2023-2028) & (US$/Unit)
Table 12. mRNA Vaccine and Therapeutics Raw Material Major Market Trends
Table 13. World mRNA Vaccine and Therapeutics Raw Material Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World mRNA Vaccine and Therapeutics Raw Material Consumption by Region (2017-2022) & (K Units)
Table 15. World mRNA Vaccine and Therapeutics Raw Material Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World mRNA Vaccine and Therapeutics Raw Material Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key mRNA Vaccine and Therapeutics Raw Material Producers in 2021
Table 18. World mRNA Vaccine and Therapeutics Raw Material Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key mRNA Vaccine and Therapeutics Raw Material Producers in 2021
Table 20. World mRNA Vaccine and Therapeutics Raw Material Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global mRNA Vaccine and Therapeutics Raw Material Company Evaluation Quadrant
Table 22. World mRNA Vaccine and Therapeutics Raw Material Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and mRNA Vaccine and Therapeutics Raw Material Production Site of Key Manufacturer
Table 24. mRNA Vaccine and Therapeutics Raw Material Market: Company Product Type Footprint
Table 25. mRNA Vaccine and Therapeutics Raw Material Market: Company Product Application Footprint
Table 26. mRNA Vaccine and Therapeutics Raw Material Competitive Factors
Table 27. mRNA Vaccine and Therapeutics Raw Material New Entrant and Capacity Expansion Plans
Table 28. mRNA Vaccine and Therapeutics Raw Material Mergers & Acquisitions Activity
Table 29. United States VS China mRNA Vaccine and Therapeutics Raw Material Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China mRNA Vaccine and Therapeutics Raw Material Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China mRNA Vaccine and Therapeutics Raw Material Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of mRNA Vaccine and Therapeutics Raw Material in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States mRNA Vaccine and Therapeutics Raw Material Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States mRNA Vaccine and Therapeutics Raw Material Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States mRNA Vaccine and Therapeutics Raw Material Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of mRNA Vaccine and Therapeutics Raw Material in China, Company Headquarters and Production Place (Province, Country)
Table 38. China mRNA Vaccine and Therapeutics Raw Material Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China mRNA Vaccine and Therapeutics Raw Material Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China mRNA Vaccine and Therapeutics Raw Material Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of mRNA Vaccine and Therapeutics Raw Material in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World mRNA Vaccine and Therapeutics Raw Material Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World mRNA Vaccine and Therapeutics Raw Material Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World mRNA Vaccine and Therapeutics Raw Material Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World mRNA Vaccine and Therapeutics Raw Material Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World mRNA Vaccine and Therapeutics Raw Material Production by Type (2017-2022) & (K Units)
Table 49. World mRNA Vaccine and Therapeutics Raw Material Production by Type (2023-2028) & (K Units)
Table 50. World mRNA Vaccine and Therapeutics Raw Material Production Value by Type (2017-2022) & (USD Million)
Table 51. World mRNA Vaccine and Therapeutics Raw Material Production Value by Type (2023-2028) & (USD Million)
Table 52. World mRNA Vaccine and Therapeutics Raw Material Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World mRNA Vaccine and Therapeutics Raw Material Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World mRNA Vaccine and Therapeutics Raw Material Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World mRNA Vaccine and Therapeutics Raw Material Production by Application (2017-2022) & (K Units)
Table 56. World mRNA Vaccine and Therapeutics Raw Material Production by Application (2023-2028) & (K Units)
Table 57. World mRNA Vaccine and Therapeutics Raw Material Production Value by Application (2017-2022) & (USD Million)
Table 58. World mRNA Vaccine and Therapeutics Raw Material Production Value by Application (2023-2028) & (USD Million)
Table 59. World mRNA Vaccine and Therapeutics Raw Material Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World mRNA Vaccine and Therapeutics Raw Material Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Jena Bioscience Basic Information, Manufacturing Base and Competitors
Table 62. Jena Bioscience Major Business
Table 63. Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 64. Jena Bioscience mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Jena Bioscience Recent Developments/Updates
Table 66. Jena Bioscience Competitive Strengths & Weaknesses
Table 67. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Thermo Fisher Scientific Inc. Major Business
Table 69. Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 70. Thermo Fisher Scientific Inc. mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 72. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 73. SBS Genetech Basic Information, Manufacturing Base and Competitors
Table 74. SBS Genetech Major Business
Table 75. SBS Genetech mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 76. SBS Genetech mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. SBS Genetech Recent Developments/Updates
Table 78. SBS Genetech Competitive Strengths & Weaknesses
Table 79. Lucigen Basic Information, Manufacturing Base and Competitors
Table 80. Lucigen Major Business
Table 81. Lucigen mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 82. Lucigen mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Lucigen Recent Developments/Updates
Table 84. Lucigen Competitive Strengths & Weaknesses
Table 85. Sigma Aldrich Basic Information, Manufacturing Base and Competitors
Table 86. Sigma Aldrich Major Business
Table 87. Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 88. Sigma Aldrich mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Sigma Aldrich Recent Developments/Updates
Table 90. Sigma Aldrich Competitive Strengths & Weaknesses
Table 91. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 92. Moderna Therapeutics Major Business
Table 93. Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 94. Moderna Therapeutics mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Moderna Therapeutics Recent Developments/Updates
Table 96. Moderna Therapeutics Competitive Strengths & Weaknesses
Table 97. CureVac Basic Information, Manufacturing Base and Competitors
Table 98. CureVac Major Business
Table 99. CureVac mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 100. CureVac mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. CureVac Recent Developments/Updates
Table 102. CureVac Competitive Strengths & Weaknesses
Table 103. Translate Bio Basic Information, Manufacturing Base and Competitors
Table 104. Translate Bio Major Business
Table 105. Translate Bio mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 106. Translate Bio mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Translate Bio Recent Developments/Updates
Table 108. Translate Bio Competitive Strengths & Weaknesses
Table 109. BioNTech Basic Information, Manufacturing Base and Competitors
Table 110. BioNTech Major Business
Table 111. BioNTech mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 112. BioNTech mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. BioNTech Recent Developments/Updates
Table 114. BioNTech Competitive Strengths & Weaknesses
Table 115. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 116. Sangamo Therapeutics Major Business
Table 117. Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 118. Sangamo Therapeutics mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Sangamo Therapeutics Recent Developments/Updates
Table 120. Sangamo Therapeutics Competitive Strengths & Weaknesses
Table 121. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 122. Argos Therapeutics Major Business
Table 123. Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 124. Argos Therapeutics mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Argos Therapeutics Recent Developments/Updates
Table 126. Argos Therapeutics Competitive Strengths & Weaknesses
Table 127. In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table 128. In-Cell-Art Major Business
Table 129. In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 130. In-Cell-Art mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. In-Cell-Art Recent Developments/Updates
Table 132. In-Cell-Art Competitive Strengths & Weaknesses
Table 133. Etherna Basic Information, Manufacturing Base and Competitors
Table 134. Etherna Major Business
Table 135. Etherna mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 136. Etherna mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Etherna Recent Developments/Updates
Table 138. Etherna Competitive Strengths & Weaknesses
Table 139. Ethris Basic Information, Manufacturing Base and Competitors
Table 140. Ethris Major Business
Table 141. Ethris mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 142. Ethris mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Ethris Recent Developments/Updates
Table 144. Ethris Competitive Strengths & Weaknesses
Table 145. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table 146. Tiba Biotechnology Major Business
Table 147. Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 148. Tiba Biotechnology mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Tiba Biotechnology Recent Developments/Updates
Table 150. Product Type Insights Basic Information, Manufacturing Base and Competitors
Table 151. Product Type Insights Major Business
Table 152. Product Type Insights mRNA Vaccine and Therapeutics Raw Material Product and Services
Table 153. Product Type Insights mRNA Vaccine and Therapeutics Raw Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 154. mRNA Vaccine and Therapeutics Raw Material Raw Material
Table 155. Key Manufacturers of mRNA Vaccine and Therapeutics Raw Material Raw Materials
Table 156. mRNA Vaccine and Therapeutics Raw Material Typical Distributors
Table 157. mRNA Vaccine and Therapeutics Raw Material Typical Customers
LIST OF FIGURES
Figure 1. mRNA Vaccine and Therapeutics Raw Material Picture
Figure 2. World mRNA Vaccine and Therapeutics Raw Material Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World mRNA Vaccine and Therapeutics Raw Material Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World mRNA Vaccine and Therapeutics Raw Material Production (2017-2028) & (K Units)
Figure 5. World mRNA Vaccine and Therapeutics Raw Material Average Price (2017-2028) & (US$/Unit)
Figure 6. World mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Region (2017-2028)
Figure 7. World mRNA Vaccine and Therapeutics Raw Material Production Market Share by Region (2017-2028)
Figure 8. North America mRNA Vaccine and Therapeutics Raw Material Production (2017-2028) & (K Units)
Figure 9. Europe mRNA Vaccine and Therapeutics Raw Material Production (2017-2028) & (K Units)
Figure 10. China mRNA Vaccine and Therapeutics Raw Material Production (2017-2028) & (K Units)
Figure 11. Japan mRNA Vaccine and Therapeutics Raw Material Production (2017-2028) & (K Units)
Figure 12. mRNA Vaccine and Therapeutics Raw Material Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World mRNA Vaccine and Therapeutics Raw Material Demand (2017-2028) & (K Units)
Figure 15. World mRNA Vaccine and Therapeutics Raw Material Consumption Market Share by Region (2017-2028)
Figure 16. United States mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028) & (K Units)
Figure 17. China mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028) & (K Units)
Figure 18. Europe mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028) & (K Units)
Figure 19. Japan mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028) & (K Units)
Figure 20. South Korea mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028) & (K Units)
Figure 21. ASEAN mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028) & (K Units)
Figure 22. India mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of mRNA Vaccine and Therapeutics Raw Material by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for mRNA Vaccine and Therapeutics Raw Material Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for mRNA Vaccine and Therapeutics Raw Material Markets in 2021
Figure 26. United States VS China: mRNA Vaccine and Therapeutics Raw Material Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: mRNA Vaccine and Therapeutics Raw Material Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: mRNA Vaccine and Therapeutics Raw Material Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of mRNA Vaccine and Therapeutics Raw Material in United States
Figure 30. Key Producers and Market Share of mRNA Vaccine and Therapeutics Raw Material in China
Figure 31. Key Producers and Market Share of mRNA Vaccine and Therapeutics Raw Material in Rest of World
Figure 32. World mRNA Vaccine and Therapeutics Raw Material Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Type in 2021
Figure 34. Infectious Disease Vaccines
Figure 35. Cancer Vaccine
Figure 36. Others
Figure 37. World mRNA Vaccine and Therapeutics Raw Material Production Market Share by Type (2017-2028)
Figure 38. World mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Type (2017-2028)
Figure 39. World mRNA Vaccine and Therapeutics Raw Material Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World mRNA Vaccine and Therapeutics Raw Material Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Application in 2021
Figure 42. Hospitals and Clinics
Figure 43. Outpatient and Surgery Centers
Figure 44. Others
Figure 45. World mRNA Vaccine and Therapeutics Raw Material Production Market Share by Application (2017-2028)
Figure 46. World mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Application (2017-2028)
Figure 47. World mRNA Vaccine and Therapeutics Raw Material Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of mRNA Vaccine and Therapeutics Raw Material in 2021
Figure 49. Manufacturing Process Analysis of mRNA Vaccine and Therapeutics Raw Material
Figure 50. mRNA Vaccine and Therapeutics Raw Material Industrial Chain
Figure 51. Distribution Channel Breakdown for mRNA Vaccine and Therapeutics Raw Material Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. mRNA Vaccine and Therapeutics Raw Material Picture
Figure 2. World mRNA Vaccine and Therapeutics Raw Material Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World mRNA Vaccine and Therapeutics Raw Material Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World mRNA Vaccine and Therapeutics Raw Material Production (2017-2028) & (K Units)
Figure 5. World mRNA Vaccine and Therapeutics Raw Material Average Price (2017-2028) & (US$/Unit)
Figure 6. World mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Region (2017-2028)
Figure 7. World mRNA Vaccine and Therapeutics Raw Material Production Market Share by Region (2017-2028)
Figure 8. North America mRNA Vaccine and Therapeutics Raw Material Production (2017-2028) & (K Units)
Figure 9. Europe mRNA Vaccine and Therapeutics Raw Material Production (2017-2028) & (K Units)
Figure 10. China mRNA Vaccine and Therapeutics Raw Material Production (2017-2028) & (K Units)
Figure 11. Japan mRNA Vaccine and Therapeutics Raw Material Production (2017-2028) & (K Units)
Figure 12. mRNA Vaccine and Therapeutics Raw Material Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World mRNA Vaccine and Therapeutics Raw Material Demand (2017-2028) & (K Units)
Figure 15. World mRNA Vaccine and Therapeutics Raw Material Consumption Market Share by Region (2017-2028)
Figure 16. United States mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028) & (K Units)
Figure 17. China mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028) & (K Units)
Figure 18. Europe mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028) & (K Units)
Figure 19. Japan mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028) & (K Units)
Figure 20. South Korea mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028) & (K Units)
Figure 21. ASEAN mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028) & (K Units)
Figure 22. India mRNA Vaccine and Therapeutics Raw Material Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of mRNA Vaccine and Therapeutics Raw Material by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for mRNA Vaccine and Therapeutics Raw Material Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for mRNA Vaccine and Therapeutics Raw Material Markets in 2021
Figure 26. United States VS China: mRNA Vaccine and Therapeutics Raw Material Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: mRNA Vaccine and Therapeutics Raw Material Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: mRNA Vaccine and Therapeutics Raw Material Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of mRNA Vaccine and Therapeutics Raw Material in United States
Figure 30. Key Producers and Market Share of mRNA Vaccine and Therapeutics Raw Material in China
Figure 31. Key Producers and Market Share of mRNA Vaccine and Therapeutics Raw Material in Rest of World
Figure 32. World mRNA Vaccine and Therapeutics Raw Material Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Type in 2021
Figure 34. Infectious Disease Vaccines
Figure 35. Cancer Vaccine
Figure 36. Others
Figure 37. World mRNA Vaccine and Therapeutics Raw Material Production Market Share by Type (2017-2028)
Figure 38. World mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Type (2017-2028)
Figure 39. World mRNA Vaccine and Therapeutics Raw Material Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World mRNA Vaccine and Therapeutics Raw Material Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Application in 2021
Figure 42. Hospitals and Clinics
Figure 43. Outpatient and Surgery Centers
Figure 44. Others
Figure 45. World mRNA Vaccine and Therapeutics Raw Material Production Market Share by Application (2017-2028)
Figure 46. World mRNA Vaccine and Therapeutics Raw Material Production Value Market Share by Application (2017-2028)
Figure 47. World mRNA Vaccine and Therapeutics Raw Material Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of mRNA Vaccine and Therapeutics Raw Material in 2021
Figure 49. Manufacturing Process Analysis of mRNA Vaccine and Therapeutics Raw Material
Figure 50. mRNA Vaccine and Therapeutics Raw Material Industrial Chain
Figure 51. Distribution Channel Breakdown for mRNA Vaccine and Therapeutics Raw Material Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
